BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862
368 results:

  • 1. MiR-29a-3p mediates phosphatase and tensin homolog and inhibits osteoarthritis progression.
    Zhu K; Zhang Y; Li D; Xie M; Jiang H; Zhang K; Lei Y; Chen G
    Funct Integr Genomics; 2024 Mar; 24(2):54. PubMed ID: 38467932
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Atypical Spindle Cell/Pleomorphic Lipomatous Tumor With Sarcomatous Transformation: Clinicopathologic and Molecular Analysis of 4 Cases.
    Perret R; Charville GW; Alame M; Rebier F; Soubeyran I; Gross JM; Graham D; Green DC; Kerr DA; Khan WA; Cloutier JM
    Mod Pathol; 2024 Apr; 37(4):100454. PubMed ID: 38417627
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Establishment and Characterization of Cell Lines from Canine Metastatic Osteosarcoma.
    Yang YT; Engleberg AI; Yuzbasiyan-Gurkan V
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201229
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genetically engineered mouse model of pleomorphic liposarcoma: Immunophenotyping and histologic characterization.
    Brown JM; Patel R; Smith-Fry K; Ward M; Oliver T; Jones KB
    Neoplasia; 2024 Feb; 48():100956. PubMed ID: 38199172
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. PROGNOSTIC IMPLICATIONS OF PD-L1 EXPRESSION AND LOSS OF pten IN PATIENTS WITH RHABDOMYOSARCOMA, EWING'S SARCOMA AND OSTEOSARCOMA.
    Abd Elmoneim HM; Huwait HF; Nafady-Hego H; Mohamed FA
    Exp Oncol; 2023 Dec; 45(3):337-350. PubMed ID: 38186021
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
    Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
    Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Factors predictive of second-line chemotherapy in soft tissue sarcoma: An analysis of the National Genomic Profiling Database.
    Mochizuki T; Ikegami M; Akiyama T
    Cancer Sci; 2024 Feb; 115(2):575-588. PubMed ID: 38115234
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain.
    Sabattini S; Baldassarro VA; Zaccone R; Calzà L; Giardino L; Vascellari M; Lorenzini L; Moretti M; Marconato L
    Vet Comp Oncol; 2024 Mar; 22(1):70-77. PubMed ID: 38112225
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Inhibition of PRL2 Upregulates pten and Attenuates Tumor Growth in Tp53-deficient Sarcoma and Lymphoma Mouse Models.
    Nguele Meke F; Bai Y; Ruiz-Avila D; Carlock C; Ayub J; Miao J; Hu Y; Li Q; Zhang ZY
    Cancer Res Commun; 2024 Jan; 4(1):5-17. PubMed ID: 38047587
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genetic Profiling Uncovers Genome-Wide Loss of Heterozygosity and Provides Insight into Mechanisms of Sarcomatoid Transformation in Chromophobe Renal Cell Carcinoma.
    Collins K; Acosta AM; Siegmund SE; Cheng L; Hirsch MS; Idrees MT
    Mod Pathol; 2024 Feb; 37(2):100396. PubMed ID: 38043790
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Biological Assessment of Shikonin and β,β-dimethylacrylshikonin Using a Cellular Myxofibrosarcoma Tumor Heterogeneity Model.
    Lohberger B; Kaltenegger H; Eck N; Glänzer D; Leithner A; Kretschmer N
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958891
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Blue light photobiomodulation induced apoptosis by increasing ROS level and regulating SOCS3 and pten/PI3K/AKT pathway in osteosarcoma cells.
    Yang J; Jiang H; Fu Q; Qin H; Li Y; Liu M
    J Photochem Photobiol B; 2023 Dec; 249():112814. PubMed ID: 37956614
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. New emerging targets in osteosarcoma therapy: pten and PI3K/Akt crosstalk in carcinogenesis.
    Sadrkhanloo M; Paskeh MDA; Hashemi M; Raesi R; Bahonar A; Nakhaee Z; Entezari M; Beig Goharrizi MAS; Salimimoghadam S; Ren J; Nabavi N; Rashidi M; Dehkhoda F; Taheriazam A; Tan SC; Hushmandi K
    Pathol Res Pract; 2023 Nov; 251():154902. PubMed ID: 37922723
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of pten/p53-Deficient Endometrial Cancers.
    Navaridas R; Vidal-Sabanés M; Ruiz-Mitjana A; Altés G; Perramon-Güell A; Yeramian A; Egea J; Encinas M; Gatius S; Matias-Guiu X; Dolcet X
    Adv Sci (Weinh); 2023 Nov; 10(32):e2303134. PubMed ID: 37749866
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Mutation Profile via Next-Generation Sequencing in Patients with Colorectal Adenocarcinoma and Its Clinicopathological Correlation.
    Osman S; Kahraman Çetin N; Erdoğdu İH; Meteoğlu İ
    Turk J Gastroenterol; 2023 Nov; 34(11):1124-1133. PubMed ID: 37737217
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The prognostic significance of the heterologous component in uterine carcinosarcomas.
    Can B; Karataşli V; Çakir İ; Sayhan S; Hansu K; Kuru O
    Rev Assoc Med Bras (1992); 2023; 69(9):e20230517. PubMed ID: 37729375
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The Targeted Therapies for Osteosarcoma
    Wang S; Ren Q; Li G; Zhao X; Zhao X; Zhang Z
    Curr Mol Pharmacol; 2024; 17(1):e210823220109. PubMed ID: 37602543
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.
    Kitazawa S; Chiyoda T; Nakamura K; Sakai K; Yoshihama T; Nishio H; Kobayashi Y; Iwata T; Banno K; Yamagami W; Nishihara H; Aoki D
    Int J Clin Oncol; 2023 Nov; 28(11):1554-1562. PubMed ID: 37574505
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. HTRA3 transcriptionally inhibited by FOXP1 suppresses tumorigenesis of osteosarcoma via the pten/PI3K/AKT pathway.
    Tong Z; Shen Y; Yuan Q; Yu H
    Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119553. PubMed ID: 37527738
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Intracranial mesenchymal tumor with (novel) COX14::pten rearrangement.
    d'Amati A; Gianno F; Scuccimarri L; Lastilla M; Messina R; Signorelli F; Zimatore DS; Barresi S; Miele E; Alaggio R; Rossi S; Maiorano E; Ingravallo G; Giangaspero F; Antonelli M
    Acta Neuropathol Commun; 2023 Jun; 11(1):95. PubMed ID: 37312212
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 19.